Hormone Drug Articles & Analysis
8 news found
Microneedles, on the other hand, are tiny needles that can penetrate the skin surface for transdermal delivery of drugs. “Our innovative drug delivery solutions are ideal for a wide range of pharmaceutical and biotech applications, such as gene therapy, immunotherapy, hormonal therapy, anti-infectives, and vaccines,” said the Marketing Chief of ...
Blockbuster potential is also attributed to elinzanetant, an innovative, non-hormonal small molecule being developed for the treatment of vasomotor symptoms during menopause. ...
ByBayer AG
Available therapeutics for endometriosis are mainly hormone-based and aim to reduce the effect of endogenous estrogen. Therefore, hormonal contraceptives, as well as agents which completely shut off estrogen production, are often used. ...
and, Adjunct Assistant Professor of Dermatology at New York University School of Medicine comments: “A large proportion of postmenopausal women need access to an effective non-hormonal topical drug that alleviates vestibulodynia, the most common cause of sexual pain. ...
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology company, announced today that it filed an Investigational New Drug Application (IND) with the FDA to move forward a radiotherapeutic drug, CTT1403, into human clinical trials for prostate cancer. CTT1403 is a peptidomimetic drug that targets Prostate Specific Membrane ...
The commercialization potential of methods to occlude the vas deferens have promise to be the first long-lasting, non-hormonal, and reversible male contraceptive approach. “With about half of all pregnancies unplanned, and the burden of birth control mostly shouldered by women, there is a huge need for effective male contraception,” said Kevin Eisenfrats. ...
A University of Wyoming spin-out business has received a $150,000 Small Business Innovation Research (SBIR) grant to improve the effectiveness of drugs that can potentially help diabetes and cancer patients. GlycoBac will use the six-month grant from the National Institutes of Health (NIH) for research to improve the effectiveness of already developed glycoprotein ...
The report by UK researchers summarises the evidence for the link between breast cancer and environmental influences. Exposure to hormone-disruptive chemicals, such as hormone replacement therapy (HRT) drugs, is thought to be a key factor, but there are other relevant chemicals found in the environment, such as pesticides and phthalates (widely ...